Posted on
Share on Facebook
Share on Twitter
Share on LinkedIn

(Reuters) – The U.S. Food and Drug Administration on Wednesday said it will temporarily allow certain manufacturers to sell blood pressure medications containing specified levels of a probable cancer-causing impurity in order to maintain adequate supplies of the drug.

Read More